The Interaction of MOZ-TIF2 with Histone Chaperon Proteins CAF-1A and Asf1b Alters MOZ Regulated Gene Expression.

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 2208-2208
Author(s):  
Hong Yin ◽  
Jonathan Glass ◽  
Kerry L. Blanchard

Abstract We have identified a MOZ-TIF2 (MT2) fusion gene containing the N-terminal portion of MOZ and the C-terminal portion of TIF2 from a patient with acute leukemia with a chromosome 8 translocation. We report here that MOZ portion of MOZ-TIF2 associates with chromatin assembly factors, CAF1 (chromatin assembly factor 1) and ASF1 (anti-silencing factor 1) in mammalian cells. Both proteins not only bring histones to newly synthesized DNA to create chromatin structure in the replication of chromosomes and DNA damage-repair processes but also contribute to regulation of global gene expression. Using the MOZ portion of MT2 as the bait in the yeast two hybrid system, we found that the MOZ portion interacted with CAF1A and Asf1b. The interactions were further verified with GST-pull down experiments. Interestingly, co-immunoprecipitation with whole cell extracts from HEK 293 cells transiently transfected with GFP fusions of MOZ, MT2, and TIF2 showed that only MOZ strongly co-precipitated with CAF1A while MT2 only weakly co-precipitated. In contrast to CAF1A, MT2 showed a 3-fold stronger binding to Asf1b than wild type MOZ in pull-down experiments using S-tagged Asf1b and EGFP-fusions of MOZ, MT2, and TIF2. Further analysis of the domains within the MOZ portion of MT2 responsible for the interaction of CAF1A and Asf1b with MT2 indicated that the binding of CAF1A predominately depended on the PHD domain of MOZ and amino acids176–327 of CAF1A. The MYST domain of MOZ was responsible for the binding of the MOZ portion of MT2 to Asf1b. To further verify the differential binding of MOZ and MT2 to CAF1A and Asf1b, we observed the co-localization of transiently expressed EGFP-MOZ and EGFP-MT2 with DsRed-CAF1A in HEK 293 and Hela cells. In the merged images the MOZ co-localization with CAF-1A was stronger than the colocalization of MT2 with CAF1A and MT2 colocalization with Asf1b was stronger than MOZ colocalization with Asf1b. The co-localization of MOZ and MT2 with CAF1A with Asf1b was seen both in interphase and metaphase of the cell cycle. During the interphase, the co-localizations appeared with chromatin DNA and during metaphase the co-localizations were separated from chromatin DNA. The later phenomenon was further demonstrated with G2/M phase reagent, nocodozole. These results suggest a differential function of MT2 interacting with two chromatin assembly factors compared to wild-type MOZ. In view of the regulation of global gene expression by CAF1A and Asf1b, we examined the gene expression profile in U937 cells stably expressing MT2. Compared to the expression profile of control cells stably transfected with pcDNA3 vector alone, MT2 caused a > 5-fold change in expression 181 genes (104 genes increasing and 77 genes decreasing expression) (p = 0.05). While overexpression of wild type MOZ also altered gene expression (>5-fold increase in 479 genes and >5-fold decrease in 118 genes) a differential gene expression signature was seen between MOZ and MT2. MT2 altered expression of 57% of the 597 MOZ regulated genes. Included in the genes that were either up or down-regulated by MT2 were genes involved in multiple cell functions such as signal transduction, cell response to stimulus, and development. These results suggest that MT2 fusion may interfere with the function of wild type MOZ in global gene expression during the development of myeloid cells by differential interaction with chromatin chaperon proteins and the altered global gene expression profile could contribute to leukemogenesis.

2010 ◽  
Vol 24 (S1) ◽  
Author(s):  
Pius Joseph ◽  
Rajendran Sellamuthu ◽  
Shengqiao Li ◽  
Michael Kashon ◽  
Michael Luster ◽  
...  

2003 ◽  
Vol 285 (5) ◽  
pp. C1109-C1115 ◽  
Author(s):  
Rangnath Mishra ◽  
Patrick Leahy ◽  
Michael S. Simonson

Endothelin (ET)-1 is a vasoconstrictor and mitogen involved in vascular remodeling. Changes in gene expression that underlie control of cell growth by ET-1 remain poorly characterized. To identify pathways of growth control we used microarrays to analyze ET-1-regulated gene expression in human mesangial cells, an important ET-1 vascular target cell in vivo. Statistical assessment of differential expression (significance analysis of microarrays) revealed upregulated transcripts for growth factors [heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF), fibroblast growth factor (FGF), interleukin (IL)-6] and downregulated transcripts for genes that inhibit growth (BAX, p27KIP1, DAD1). Consistent with the gene expression profile, quantitative RT-PCR and Western blotting confirmed induction of HB-EGF by ET-1. To test a functional role for HB-EGF in ET-1 signaling, we showed that exogenous HB-EGF stimulated phosphorylation of ErbB1 and growth of mesangial cells. ET-1-induced proliferation was blocked by an ErbB1 receptor-selective kinase inhibitor and by a specific ErbB1 receptor-neutralizing antibody. Proliferation in response to ET-1 was also inhibited by neutralizing antisera against human HB-EGF. Together, these results provide data for modeling ET-1 pathways for growth control and suggest a specific role for HB-EGF gene induction in mesangial cell growth in response to ET-1.


2010 ◽  
Vol 104 (7) ◽  
pp. 941-950 ◽  
Author(s):  
Kenji Saito ◽  
Yutaka Ohta ◽  
Manabu Sami ◽  
Tomomasa Kanda ◽  
Hisanori Kato

Recent transcriptomics studies on the effect of long-term or severe energy restriction (ER) have revealed that many genes are dynamically modulated by this condition in rodents. The present study was conducted to define the global gene expression profile in response to mild ER treatment. Growing rats were fed with reduced amount of diet (5–30 % ER) for 1 week or 1 month. Using DNA microarray analysis of the liver, seventy-two genes that were consistently changed through the different ER levels were identified. Many were related to lipid metabolism including genes encoding key enzymes such as carnitine palmitoyltransferase 1 and fatty acid synthase. Interestingly, a number of genes were altered even by 5 % ER for 1 week where no differences in weight gain were observed. The information obtained in the present study can be used as a valuable reference data source in the transcriptomics studies of food and nutrition in which subtle differences in food intake sometimes hinder appropriate interpretation of the data.


2011 ◽  
Vol 17 (21-22) ◽  
pp. 2817-2831 ◽  
Author(s):  
Shaza B. Idris ◽  
Anne Isine Bolstad ◽  
Salah O. Ibrahim ◽  
Staffan Dånmark ◽  
Anna Finne-Wistrand ◽  
...  

Stem Cells ◽  
2006 ◽  
Vol 24 (3) ◽  
pp. 631-641 ◽  
Author(s):  
Taina Jaatinen ◽  
Heidi Hemmoranta ◽  
Sampsa Hautaniemi ◽  
Jari Niemi ◽  
Daniel Nicorici ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document